DMPK基因CTG扩增:精液质量评估与植入前遗传学诊断结局
该单中心回顾性观察研究于2003年1月至2019年1月在法国Antoine Béclère大学医院开展,比较男性1型强直性肌营养不良(DM1)患者(A组,n=18)、DM1女性患者未受累伴侣(B组,n=30)与已证实生育力男性(C组,n=33)的精液质量及植入前遗传学诊断(PGD)结局。A组精液量、前向运动活力和精子制备后前向运动精子中位数均低于B组和C组,精子活力与CTG重复数呈负相关,A组与B组每次移植累计活产率相似。作者建议对受累男性定期监测精液质量,以便精液参数下降时行精子冷冻保存。
要点
- A组精液量2.0 mL低于B组3.0 mL和C组3.5 mL(均P < 0.01)。
- A组精子制备后前向运动精子中位数2.7 M低于B组10.0 M和C组62.2 M(均P < 0.01)。
- 每次移植累计活产率A组32.2% vs B组26.8%,两组相似。
核心结论
- 精子活力与CTG重复数呈负相关(Spearman r2 = 0.48,Pearson r2 = 0.35)。
- 作者建议医生对受累男性定期监测精液质量,以便精液参数下降时行精子冷冻保存。
- PGD可获得良好生殖结局且不传播疾病。
研究设计与样本
- 单中心回顾性观察研究,2003年1月至2019年1月于法国Clamart的Antoine Béclère大学医院开展。
- 比较三组:男性DM1患者(A组,n = 18)、DM1女性患者未受累伴侣(B组,n = 30)、已证实生育力男性(C组,n = 33)。
- A组与B组比较PGD后的生殖结局。
主要发现
- A组精液量2.0 mL,低于B组3.0 mL(P < 0.01)和C组3.5 mL(P < 0.01)。
- A组原始精液前向运动活力30%,低于C组40%(P < 0.01)。
- A组精子制备后前向运动精子中位数2.7 M,低于B组10.0 M(P < 0.01)和C组62.2 M(P < 0.01)。
- 精子活力与CTG重复数呈负相关(Spearman r2 = 0.48,Pearson r2 = 0.35)。
- 每次移植累计活产率A组32.2% vs B组26.8%,两组相似。
关键数值与推荐
- A组精液量2.0 mL vs B组3.0 mL(P < 0.01)vs C组3.5 mL(P < 0.01)。
- A组原始精液前向运动活力30% vs C组40%(P < 0.01)。
- A组精子制备后前向运动精子中位数2.7 M vs B组10.0 M(P < 0.01)vs C组62.2 M(P < 0.01)。
- 精子活力与CTG重复数:Spearman r2 = 0.48,Pearson r2 = 0.35。
- 每次移植累计活产率A组32.2% vs B组26.8%。
临床怎么用
- 作者建议医生对受累男性定期监测精液质量,以便精液参数下降时行精子冷冻保存。
- PGD可获得良好生殖结局且不传播疾病。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Myotonic dystrophy (DM) is an autosomal dominant disorder characterized mainly by myotonia but also by primary hypogonadism. No study has reported on fertility management of patients affected by DM type 1 (DM1). OBJECTIVE: This study investigates the impact of CTG repeats in the DMPK gene on semen quality and preimplantation genetic diagnosis (PGD) outcome. DESIGN: This is a monocentric retrospective observational study conducted from January 2003 to January 2019. SETTING: Antoine Béclère University Hospital, Clamart, France. PATIENTS: Three groups were compared in this study: male DM1 patients (Group A, n = 18), unaffected partners of DM1 female patients (Group B, n = 30), and proven fertile men (Group C, n = 33). Reproductive outcomes after PGD were compared between groups A and B. RESULTS: Sperm volume was reduced in group A (2.0 mL) when compared with groups B (3.0 mL; P < 0.01) and C (3.5 mL; P < 0.01). Progressive motility in raw sperm was also decreased in group A (30%) as compared to group C (40%; P < 0.01). The median number of progressive spermatozoa retrieved after sperm preparation was 2.7 million (M) in group A, which was significantly less than those of groups B (10.0 M; P < 0.01) and C (62.2 M; P < 0.01). Sperm motility was inversely correlated to the number of CTG repeats (Spearman r2 = 0.48, Pearson r2 = 0.35). Cumulative live birth rate per transfer was similar between groups, with 32.2% in group A versus 26.8% in group B. CONCLUSIONS: As a precautionary measure, we advise physicians to perform regular monitoring of semen quality in affected males, which would allow sperm cryopreservation should semen parameters fall. PGD allows good reproductive outcomes without disease transmission.
引用
- Puy V, Mayeur A, Levy A, et al. CTG Expansion in the DMPK Gene: Semen Quality Assessment and Outcome of Preimplantation Genetic Diagnosis. J Clin Endocrinol Metab. 2020. PMID: 31996899. doi:10.1210/clinem/dgaa041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。